How Mark Cuban’s New Drug Company Sells Medications With Huge Discounts
awsforwp,
What’s happening Mark Cuban started a company that offers generic versions of medication at extremely low prices.
How Mark Cuban's New Drug Company Sells Medications With Huge Discounts
CNET,
What's happening Mark Cuban started a company that offers generic versions of medication at extremely low prices.
Prices for New Drugs Are Rising 20 Percent a Year. Congress Needs to Act.
DNYUZ,
Millions of Americans are forced to ration or go without prescription drugs because of their high cost.
Big Pharma Handling Vaccine Rollout Was A Mistake
The ASEAN Post,
Pfizer has had an exceptionally good pandemic. The company announced that its COVID-19 vaccine brought in US$37 billion last…
Will parents trust Pfizer’s pediatric vaccine after a new postponement?
Poynter,
Plus, new data says a fourth dose might be necessary, vaccines are working well for teens, remdesivir appears to work against…
Letting big pharma lead the global vaccine rollout was a mistake - Taipei Times
Taipei Times,
The COVID-19 pandemic made one fact perfectly clear: Pharmaceutical companies and their shareholders only care about huge…
Putting big pharma in charge of global vaccine rollout was a big mistake | Nick Dearden
Google News,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake
MSN,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake | Nick Dearden
Newsbreak,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake | Nick Dearden
Tech Register,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake | Nick Dearden
Newscabal,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake
Yahoo! News,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Putting big pharma in charge of global vaccine rollout was a big mistake | Nick Dearden
The Guardian,
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year…
Comment: Negotiating drug prices won’t hurt innovation
HeraldNet,
By Aaron S. Kesselheim and Jerry Avorn / Special To The Washington Post For years, the pharmaceutical industry has managed to…
Letting the government negotiate drug prices won’t hurt innovation
Washington Post,
For years, the pharmaceutical industry has managed to fend off legislative efforts to tame America’s brand-name medication…
One key study highlights how cancer-drug prices continue to rise in the US - even if they don't elsewhere
MSN,
There is increasing interest in the federal government in lowering prescription drug prices.
One key study highlights how cancer-drug prices continue to rise in the US - even if they don't elsewhere
Newsbreak,
There is increasing interest in the federal government in lowering prescription drug prices.
One key study highlights how cancer-drug prices continue to rise in the US — even if they don't elsewhere
Business Insider,
There is increasing interest in the federal government in lowering prescription drug prices.
One key study highlights how cancer-drug prices continue to rise in the US - even if they don't elsewhere
Business Insider India,
As the federal government considers a plan to lower the price of some costly drugs, researchers have found that while US cancer-d…
One key study highlights how cancer-drug prices continue to rise in the US - even if they don't elsewhere
Business Insider Australia ,
There is increasing interest in the federal government in lowering prescription drug prices.
Government regulated or negotiated drug prices: Key design considerations
Brookings,
By Paul Ginsburg, Steven M. Lieberman Government regulated or negotiated drug prices: Key design considerations Paul B.
News story from Gizmodo Australia on Tuesday 04 May 2021
Gizmodo Australia,
News story from Gizmodo on Tuesday 04 May 2021
Gizmodo,
March-In Rights And Compulsory Licensing—Safety Nets For Access To A COVID-19 Vaccine
Health Affairs,
In 1955, journalist Edward R. Murrow asked Jonas Salk: Who owns the patent to the polio vaccine? He responded famously, “Well…
Single-Payer Drug Pricing In A Multipayer Health System: Does Germany Offer A Model For The US?
Health Affairs,
An increasing number of presidential hopefuls, most recently Senator Kamala Harris, are proposing “single payer” or “Medicare…
Drug Prices by Committee: One Way Biden Could Lower Costs
New York Times,
The New Health Care Many countries use independent review boards to balance innovation and profit.
Blame medication price gouging on spineless politicians
Newsbreak,
Thought Catalog/Unsplash An article published in Journal of the American Medical Association spells out just why prescription…
Balancing Lower U.S. Prescription Drug Prices And Innovation – Part 2
Health Affairs,
In Part 1 of this post, we provided background on U.S. drug prices and summarized an expert roundtable discussion held in June…
Balancing Lower U.S. Prescription Drug Prices And Innovation – Part 1
Health Affairs,
Most Americans believe U.S. prescription drug prices are too high—a conclusion reinforced by almost 3 in 10 Americans reporting…
Balancing lower U.S. prescription drug prices and innovation – Part 1
Brookings,
By Steven M. Lieberman, Paul Ginsburg, Kavita Patel Most Americans believe U.S.
Stop Paying Too Much For Your IPOs - Get GoodRx Today
Seeking Alpha,
Summary GoodRx has managed to marry technology with a lasting, polarizing and colossal issue impacting society - healthcare…
March-In Rights And Compulsory Licensing—Safety Nets For Access To A COVID-19 Vaccine
Health Affairs,
In 1955, journalist Edward R. Murrow asked Jonas Salk: Who owns the patent to the polio vaccine? He responded famously, “Well…
News story from Eurasia Review on Wednesday 25 March 2020
Eurasia Review,
The Decade of Transformation Is Here: Remaking Health Care
Globalresearch,
We’ve been writing for a while that the 2020’s would be a decade when multiple crises would come to a head and we would have an…
Fact check: Is Big Pharma’s take on the Pelosi drug-pricing bill fair warning or fearmongering?
Bozeman Daily Chronicle,
House Speaker Nancy Pelosi’s flagship proposal to curb prescription drug prices, the “Lower Drug Costs Now Act” — H.R.
Pharma’s take on the Pelosi drug-pricing bill: Fair warning or fearmongering?
The Medical News,
House Speaker Nancy Pelosi's flagship proposal to curb prescription drug prices, the "Lower Drug Costs Now Act" - H.R.
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
Lancaster Online,
House Speaker Nancy Pelosi’s flagship proposal to curb prescription drug prices, the “Lower Drug Costs Now Act” ― H.R.
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
The Record,
[khn—slabs slabs="1027675" view="inline" /] [partner-box]House Speaker Nancy Pelosi’s flagship proposal to curb prescription…
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
Kaiser Health News,
“Speaker Pelosi’s drug pricing plan would siphon $1 trillion or more from biopharmaceutical innovators over the next 10 years.
House Commerce Committee Issues Hearing Memo on Making Prescription Drugs More Affordable
Insurance News Net,
Targeted News Service WASHINGTON, Sept. 18 -- The House Energy and Commerce Committee issued the following hearing memorandum…
Why a plan to lower prescription drug prices should not be piecemeal
MedicalXpress,
A man looks at a prescription drug bottle. Many Americans will chronic conditions report rationing their drugs because of cost.
Why a plan to lower prescription drug prices should not be piecemeal
Toronto Telegraph,
Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic…
News story from Big News Network on Tuesday 10 September 2019
Big News Network,
MIL-OSI Global: Why a plan to lower prescription drug prices should not be piecemeal
Foreign Affairs New Zealand,
Post sponsored by NewzEngine.com Source: The Conversation – USA – By Minal R. Patel, Associate Professor of Health Behavior
Why a plan to lower prescription drug prices should not be piecemeal
Idaho Press,
( is an independent and nonprofit source of news, analysis and commentary from academic experts.), and, (THE CONVERSATION…
Why a plan to lower prescription drug prices should not be piecemeal
Lincoln Journal Star,
(THE CONVERSATION) Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at…
Why a plan to lower prescription drug prices should not be piecemeal
SFGate,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Minal R.
Why a plan to lower prescription drug prices should not be piecemeal
Seattle Post-Intelligencer,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Minal R.
Why a plan to lower prescription drug prices should not be piecemeal
The Conversation,
Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic…
Price of snakebite drug is sky high, likely to stay that way
Union Leader,
Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented…
Price of snakebite drug is sky high, but new competitor unlikely to lower costs
The Medical News,
Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented…
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WCBE ,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KOSU,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KTEP El Paso,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Radio Acadie,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Omaha Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Witchita's Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KCLU,
Tais Policanti / Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites…
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
North East Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KUNM,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KRWG TV/FM,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KERA News,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Kansas City University Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
New Hampshire Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Central Coast Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
New England Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Arizona Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Northeastern Indiana Public Radio ,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
SDPB Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
A Koahnic Broadcast Station,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WYPR,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WRKF,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Interlochen Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Price Of Snakebite Drug Is Sky High, But New Competitor Unlikely To Lower Costs
Fox News 26,
Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented…
Price Of Snakebite Drug Is Sky High, But New Competitor Unlikely To Lower Costs
Kaiser Health News,
Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented…
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
KPBS,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WUKY,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Delmarva Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
The University of New Orleans Public Radio ,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WXPR,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WVPE,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WVTF,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WKAR,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WUNC,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WUWM,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WLRN,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WVXU,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Northern Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Iowa Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
WJCT,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Wyoming Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Boise State Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Kansas Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Tri States Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Georgia Public Radio,
Dr. Steven Curry, a medical toxicologist and professor at the University of Arizona, has treated snakebites since the 1980s …
Der Überlebenswille ist eingepreist
ZEIT ONLINE,
Die Pharmabranche ist kaum reguliert, die Patienten haben kaum eine Wahl: Wer in den USA Medikamente braucht, verzweifelt oft…
Trump Plans New ‘Favored Nations Clause’ to Tie Drug Prices to the Cost Other...
Biospace,
Nicole S Glass / Shutterstock In his latest move to drive down the costs of prescription drugs in the United States, President…
U.S. Companies Continue to Pay More in Healthcare as the Cost of Drugs Keeps ...
Biospace,
The rising cost of healthcare has been a hot topic of discussion as of late throughout the United States, with many…
Pharmacist Involvement in Population Health Management for a Pediatric Managed Medicaid ...
Medical Health News,
Review Pharmacist Involvement in Population Health Management for a Pediatric Managed Medicaid Accountable Care Organization…
Opinion: Negotiating drug prices without restricting patient access: lessons from Germany
Yahoo! News,
In the ongoing conversation about high drug prices in the United States, some loud voices argue that the solution is to allow…